Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor, sending its shares up 25% in morning trade.

LONDON & SAN FRANCISCO-- (BUSINESS WIRE)--December 16, 2025-- ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved Ezmekly (mirdametinib) for the treatment of ...

Pregnant people who received a COVID-19 vaccine were far less likely to experience severe illness or deliver their babies prematurely, according to a major new UBC-led study published in JAMA. Drawing ...

Remco Evenepoel was named as the Belgian Sportsman of the Year for a fifth consecutive time on Sunday, with Eddy Merckx's ...

Early and sustained ctDNA clearance in early breast cancer treated with neoadjuvant HER2-targeted therapy tracks closely with pathologic complete response to treatment and 3-year outcomes.

A new study provides more evidence that many patients with early-stage breast cancer may avoid sentinel lymph node surgery ...

On paper, cultivated meat looks like a no-brainer. Unlike plant- or fungi-based options, it has the allure of “real” meat ...

Allied Market Research published a report, titled, "Immunostimulant Market by Product Type (Vaccines, Colony Stimulating Factors, ...

Physiomics ( ($GB:PYC) ) has shared an announcement. Physiomics plc announced a new contract with Numab Therapeutics AG to support the ...